Status:
UNKNOWN
Study of the Clinical Benefits of Different Formulations of Amphotericin B
Lead Sponsor:
Qianfoshan Hospital
Conditions:
Efficacy
Safety
Eligibility:
All Genders
Brief Summary
This project intends to carry out a multi-center retrospective observational real-world study to understand the current status of amphotericin B use by formulation type, compare the differences in saf...
Detailed Description
The researchers selected patients with amphotericin B use records discharged from five tertiary hospitals across the country from January 1, 2020 to the present, extracted data according to the inclus...
Eligibility Criteria
Inclusion
- Patients discharged from January 1, 2020 to the present;
- Patients with a record of amphotericin B use.
Exclusion
- Key information missing from patient studies.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT06123832
Start Date
September 1 2023
End Date
December 31 2024
Last Update
October 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rui Yang,MD
Jinan, Shandong, China